The Biologic Drugs Sales Market has been growing at a faster pace with significant growth rates during the last few years and is anticipated to grow significantly in the forecast period from 2021 to 2027.
According to XYZResearch study, over the next five years the Biologic Drugs Sales market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Biologic Drugs Sales business.
Biologic Drugs market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO. The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Biologic Drugs for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Biologic Drugs market competition by top manufacturers/players, with Biologic Drugs sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biologic Drugs for each application, including
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
Feel free to let me know if you have any special requirements.
Table of Contents
1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Biologic Drugs Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Humira
2.1.2 Remicade
2.1.3 Rituxan
2.1.4 Enbrel
2.1.5 Lantus
2.1.6 Avastin
2.1.7 Herceptin
2.1.8 Others
2.2 Overall Market Performance(Value)
2.2.1 Humira
2.2.2 Remicade
2.2.3 Rituxan
2.2.4 Enbrel
2.2.5 Lantus
2.2.6 Avastin
2.2.7 Herceptin
2.2.8 Others
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Diabetes
3.1.2 Inflammation
3.1.3 Auto-Immune Diseases
3.1.4 Blood Diseases
3.1.5 Cardiovascular Diseases
3.1.6 Others
4 Manufacturers Profiles/Analysis
4.1 Roche
4.1.1 Roche Profiles
4.1.2 Roche Product Information
4.1.3 Roche Biologic Drugs Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 Roche SWOT Analysis
4.2 Abbott Laboratories
4.2.1 Abbott Laboratories Profiles
4.2.2 Abbott Laboratories Product Information
4.2.3 Abbott Laboratories Biologic DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Abbott Laboratories SWOT Analysis
4.3 Johnson & Johnson
4.3.1 Johnson & Johnson Profiles
4.3.2 Johnson & Johnson Product Information
4.3.3 Johnson & Johnson Biologic DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Johnson & Johnson SWOT Analysis
4.4 Merck & Co.
4.4.1 Merck & Co. Profiles
4.4.2 Merck & Co. Product Information
4.4.3 Merck & Co. Biologic DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.4.4 Merck & Co. SWOT Analysis
4.5 Pfizer
4.5.1 Pfizer Profiles
4.5.2 Pfizer Product Information
4.5.3 Pfizer Biologic DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.5.4 Pfizer SWOT Analysis
4.6 Amgen
4.6.1 Amgen Profiles
4.6.2 Amgen Product Information
4.6.3 Amgen Biologic DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.6.4 Amgen SWOT Analysis
4.7 Sanofi
4.7.1 Sanofi Profiles
4.7.2 Sanofi Product Information
4.7.3 Sanofi Biologic DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.7.4 Sanofi SWOT Analysis
4.8 Novartis
4.8.1 Novartis Profiles
4.8.2 Novartis Product Information
4.8.3 Novartis Biologic DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.8.4 Novartis SWOT Analysis
4.9 Eli Lilly
4.9.1 Eli Lilly Profiles
4.9.2 Eli Lilly Product Information
4.9.3 Eli Lilly Biologic DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.9.4 Eli Lilly SWOT Analysis
4.10 Amgen
4.10.1 Amgen Profiles
4.10.2 Amgen Product Information
4.10.3 Amgen Biologic DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.10.4 Amgen SWOT Analysis
5 Market Performance for Manufacturers
5.1 Global Biologic Drugs Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global Biologic Drugs Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global Biologic Drugs Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Biologic Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Biologic Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Biologic Drugs Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Biologic Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA Biologic Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA Biologic Drugs Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Biologic Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe Biologic Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe Biologic Drugs Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Biologic Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan Biologic Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan Biologic Drugs Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Biologic Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea Biologic Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea Biologic Drugs Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Biologic Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India Biologic Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India Biologic Drugs Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Biologic Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia Biologic Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia Biologic Drugs Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Biologic Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America Biologic Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America Biologic Drugs Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global Biologic Drugs Market Assessment by Regions (2014-2020)
7.1 Global Biologic Drugs Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global Biologic Drugs Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global Biologic Drugs Price (USD/Unit) by Regions 2014-2020
7.4 Global Biologic Drugs Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global Biologic Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China Biologic Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA Biologic Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe Biologic Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan Biologic Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea Biologic Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India Biologic Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Biologic Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Biologic Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Diabetes Industry
11.2 Inflammation Industry
11.3 Auto-Immune Diseases Industry
11.4 Blood Diseases Industry
11.5 Cardiovascular Diseases Industry
11.6 Others Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global Biologic Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global Biologic Drugs Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Biologic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA Biologic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe Biologic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan Biologic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea Biologic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India Biologic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia Biologic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America Biologic Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Humira
12.2.3 Remicade
12.2.4 Rituxan
12.2.5 Enbrel
12.2.6 Lantus
12.2.7 Avastin
12.2.8 Herceptin
12.2.9 Others
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Diabetes
12.3.3 Inflammation
12.3.4 Auto-Immune Diseases
12.3.5 Blood Diseases
12.3.6 Cardiovascular Diseases
12.3.7 Others
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Biologic Drugs Price (USD/Unit) Trend 2021-2026
12.4.2 Global Biologic Drugs Gross Profit Trend 2021-2026
13 Conclusion
List of Tables and Figures
Figure Product Picture of Biologic Drugs
Table Product Specifications of Biologic Drugs
Table Manufacturers List in the Report
Table Manufacturers Production Market Share (%) 2014-2020
Table Regions Overview in 2020
Table Product Type and Standard
Table Type Overview in 2020
Table Product Application and Standard
Table Application Overview in 2020
Figure Industry Chain Structure of Biologic Drugs
Table Industry News List of Biologic Drugs
Table Key Challenges
Table Global Biologic Drugs Sales (K Units) by Types
Figure Global Biologic Drugs Sales Market Share (%) by Types in 2014
Figure Global Biologic Drugs Sales Market Share (%) by Types in 2020
Table Humira Sales (K Units) and Growth Rate
Figure Humira Sales (K Units) and Growth Rate
Table Remicade Sales (K Units) and Growth Rate
Figure Remicade Sales (K Units) and Growth Rate
Table Rituxan Sales (K Units) and Growth Rate
Figure Rituxan Sales (K Units) and Growth Rate
Table Enbrel Sales (K Units) and Growth Rate
Figure Enbrel Sales (K Units) and Growth Rate
Table Lantus Sales (K Units) and Growth Rate
Figure Lantus Sales (K Units) and Growth Rate
Table Avastin Sales (K Units) and Growth Rate
Figure Avastin Sales (K Units) and Growth Rate
Table Herceptin Sales (K Units) and Growth Rate
Figure Herceptin Sales (K Units) and Growth Rate
Table Others Sales (K Units) and Growth Rate
Figure Others Sales (K Units) and Growth Rate
Table Global Biologic Drugs Revenue (M USD) by Types
Figure Global Biologic Drugs Revenue Market Share (%) by Types in 2014
Figure Global Biologic Drugs Revenue Market Share (%) by Types in 2020
Table Humira Revenue (M USD) and Growth Rate
Figure Humira Revenue (M USD) and Growth Rate
Table Remicade Revenue (M USD) and Growth Rate
Figure Remicade Revenue (M USD) and Growth Rate
Table Rituxan Revenue (M USD) and Growth Rate
Figure Rituxan Revenue (M USD) and Growth Rate
Table Enbrel Revenue (M USD) and Growth Rate
Figure Enbrel Revenue (M USD) and Growth Rate
Table Lantus Revenue (M USD) and Growth Rate
Figure Lantus Revenue (M USD) and Growth Rate
Table Avastin Revenue (M USD) and Growth Rate
Figure Avastin Revenue (M USD) and Growth Rate
Table Herceptin Revenue (M USD) and Growth Rate
Figure Herceptin Revenue (M USD) and Growth Rate
Table Others Revenue (M USD) and Growth Rate
Figure Others Revenue (M USD) and Growth Rate
Table Global Biologic Drugs Sales (K Units) by Application 2014-2020
Figure Global Biologic Drugs Sales Market Share (%) by Application in 2014
Figure Global Biologic Drugs Sales Market Share (%) by Application in 2020
Table Diabetes Sales (K Units) and Growth Rate 2014-2020
Figure Diabetes Sales (K Units) and Growth Rate 2014-2020
Table Inflammation Sales (K Units) and Growth Rate 2014-2020
Figure Inflammation Sales (K Units) and Growth Rate 2014-2020
Table Auto-Immune Diseases Sales (K Units) and Growth Rate 2014-2020
Figure Auto-Immune Diseases Sales (K Units) and Growth Rate 2014-2020
Table Blood Diseases Sales (K Units) and Growth Rate 2014-2020
Figure Blood Diseases Sales (K Units) and Growth Rate 2014-2020
Table Cardiovascular Diseases Sales (K Units) and Growth Rate 2014-2020
Figure Cardiovascular Diseases Sales (K Units) and Growth Rate 2014-2020
Table Others Sales (K Units) and Growth Rate 2014-2020
Figure Others Sales (K Units) and Growth Rate 2014-2020
Table Roche Profiles
Table Roche Product Information
Table Roche Biologic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Roche Biologic Drugs Sales Change 2014-2020
Table Roche Biologic Drugs Market Status Change 2014-2020
Table Abbott Laboratories Profiles
Table Abbott Laboratories Product Information
Table Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Abbott Laboratories Biologic Drugs Sales Change 2014-2020
Table Abbott Laboratories Biologic Drugs Market Status Change 2014-2020
Table Johnson & Johnson Profiles
Table Johnson & Johnson Product Information
Table Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Johnson & Johnson Biologic Drugs Sales Change 2014-2020
Table Johnson & Johnson Biologic Drugs Market Status Change 2014-2020
Table Merck & Co. Profiles
Table Merck & Co. Product Information
Table Merck & Co. Biologic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Merck & Co. Biologic Drugs Sales Change 2014-2020
Table Merck & Co. Biologic Drugs Market Status Change 2014-2020
Table Pfizer Profiles
Table Pfizer Product Information
Table Pfizer Biologic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Pfizer Biologic Drugs Sales Change 2014-2020
Table Pfizer Biologic Drugs Market Status Change 2014-2020
Table Amgen Profiles
Table Amgen Product Information
Table Amgen Biologic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Amgen Biologic Drugs Sales Change 2014-2020
Table Amgen Biologic Drugs Market Status Change 2014-2020
Table Sanofi Profiles
Table Sanofi Product Information
Table Sanofi Biologic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Sanofi Biologic Drugs Sales Change 2014-2020
Table Sanofi Biologic Drugs Market Status Change 2014-2020
Table Novartis Profiles
Table Novartis Product Information
Table Novartis Biologic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Novartis Biologic Drugs Sales Change 2014-2020
Table Novartis Biologic Drugs Market Status Change 2014-2020
Table Eli Lilly Profiles
Table Eli Lilly Product Information
Table Eli Lilly Biologic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Eli Lilly Biologic Drugs Sales Change 2014-2020
Table Eli Lilly Biologic Drugs Market Status Change 2014-2020
Table Amgen Profiles
Table Amgen Product Information
Table Amgen Biologic Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Amgen Biologic Drugs Sales Change 2014-2020
Table Amgen Biologic Drugs Market Status Change 2014-2020
Table Global Biologic Drugs Sales (K Units) of Manufacturers 2014-2020
Table Global Biologic Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure Global Biologic Drugs Sales Market Share (%) in 2014
Figure Global Biologic Drugs Sales Market Share (%) in 2020
Table Global Biologic Drugs Revenue (M USD) of Manufacturers 2014-2020
Table Global Biologic Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure Global Biologic Drugs Revenue Market Share (%) in 2014
Figure Global Biologic Drugs Revenue Market Share (%) in 2020
Table Global Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure Global Biologic Drugs Price (USD/Unit) of Manufacturers in 2014
Figure Global Biologic Drugs Price (USD/Unit) of Manufacturers in 2020
Table Global Biologic Drugs Gross Margin of Manufacturers 2014-2020
Figure Global Biologic Drugs Gross Margin of Manufacturers in 2014
Figure Global Biologic Drugs Gross Margin in 2020
Figure Global Biologic Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table USA Biologic Drugs Sales (K Units) of Manufacturers 2014-2020
Table USA Biologic Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure USA Biologic Drugs Sales Market Share (%) in 2014
Figure USA Biologic Drugs Sales Market Share (%) in 2020
Table USA Biologic Drugs Revenue (M USD) of Manufacturers 2014-2020
Table USA Biologic Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure USA Biologic Drugs Revenue Market Share (%) in 2014
Figure USA Biologic Drugs Revenue Market Share (%) in 2020
Table USA Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure USA Biologic Drugs Price (USD/Unit) of Manufacturers in 2014
Figure USA Biologic Drugs Price (USD/Unit) of Manufacturers in 2020
Table USA Biologic Drugs Gross Margin of Manufacturers 2014-2020
Figure USA Biologic Drugs Gross Margin of Manufacturers in 2014
Figure USA Biologic Drugs Gross Margin in 2020
Figure USA Biologic Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Europe Biologic Drugs Sales (K Units) of Manufacturers 2014-2020
Table Europe Biologic Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure Europe Biologic Drugs Sales Market Share (%) in 2014
Figure Europe Biologic Drugs Sales Market Share (%) in 2020
Table Europe Biologic Drugs Revenue (M USD) of Manufacturers 2014-2020
Table Europe Biologic Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure Europe Biologic Drugs Revenue Market Share (%) in 2014
Figure Europe Biologic Drugs Revenue Market Share (%) in 2020
Table Europe Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure Europe Biologic Drugs Price (USD/Unit) of Manufacturers in 2014
Figure Europe Biologic Drugs Price (USD/Unit) of Manufacturers in 2020
Table Europe Biologic Drugs Gross Margin of Manufacturers 2014-2020
Figure Europe Biologic Drugs Gross Margin of Manufacturers in 2014
Figure Europe Biologic Drugs Gross Margin in 2020
Figure Europe Biologic Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Japan Biologic Drugs Sales (K Units) of Manufacturers 2014-2020
Table Japan Biologic Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure Japan Biologic Drugs Sales Market Share (%) in 2014
Figure Japan Biologic Drugs Sales Market Share (%) in 2020
Table Japan Biologic Drugs Revenue (M USD) of Manufacturers 2014-2020
Table Japan Biologic Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure Japan Biologic Drugs Revenue Market Share (%) in 2014
Figure Japan Biologic Drugs Revenue Market Share (%) in 2020
Table Japan Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure Japan Biologic Drugs Price (USD/Unit) of Manufacturers in 2014
Figure Japan Biologic Drugs Price (USD/Unit) of Manufacturers in 2020
Table Japan Biologic Drugs Gross Margin of Manufacturers 2014-2020
Figure Japan Biologic Drugs Gross Margin of Manufacturers in 2014
Figure Japan Biologic Drugs Gross Margin in 2020
Figure Japan Biologic Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Korea Biologic Drugs Sales (K Units) of Manufacturers 2014-2020
Table Korea Biologic Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure Korea Biologic Drugs Sales Market Share (%) in 2014
Figure Korea Biologic Drugs Sales Market Share (%) in 2020
Table Korea Biologic Drugs Revenue (M USD) of Manufacturers 2014-2020
Table Korea Biologic Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure Korea Biologic Drugs Revenue Market Share (%) in 2014
Figure Korea Biologic Drugs Revenue Market Share (%) in 2020
Table Korea Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure Korea Biologic Drugs Price (USD/Unit) of Manufacturers in 2014
Figure Korea Biologic Drugs Price (USD/Unit) of Manufacturers in 2020
Table Korea Biologic Drugs Gross Margin of Manufacturers 2014-2020
Figure Korea Biologic Drugs Gross Margin of Manufacturers in 2014
Figure Korea Biologic Drugs Gross Margin in 2020
Figure Korea Biologic Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table India Biologic Drugs Sales (K Units) of Manufacturers 2014-2020
Table India Biologic Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure India Biologic Drugs Sales Market Share (%) in 2014
Figure India Biologic Drugs Sales Market Share (%) in 2020
Table India Biologic Drugs Revenue (M USD) of Manufacturers 2014-2020
Table India Biologic Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure India Biologic Drugs Revenue Market Share (%) in 2014
Figure India Biologic Drugs Revenue Market Share (%) in 2020
Table India Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure India Biologic Drugs Price (USD/Unit) of Manufacturers in 2014
Figure India Biologic Drugs Price (USD/Unit) of Manufacturers in 2020
Table India Biologic Drugs Gross Margin of Manufacturers 2014-2020
Figure India Biologic Drugs Gross Margin of Manufacturers in 2014
Figure India Biologic Drugs Gross Margin in 2020
Figure India Biologic Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Southeast Asia Biologic Drugs Sales (K Units) of Manufacturers 2014-2020
Table Southeast Asia Biologic Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure Southeast Asia Biologic Drugs Sales Market Share (%) in 2014
Figure Southeast Asia Biologic Drugs Sales Market Share (%) in 2020
Table Southeast Asia Biologic Drugs Revenue (M USD) of Manufacturers 2014-2020
Table Southeast Asia Biologic Drugs Revenue Market Share (%) of Manufacturers 2014-2020
Figure Southeast Asia Biologic Drugs Revenue Market Share (%) in 2014
Figure Southeast Asia Biologic Drugs Revenue Market Share (%) in 2020
Table Southeast Asia Biologic Drugs Price (USD/Unit) of Manufacturers 2014-2020
Figure Southeast Asia Biologic Drugs Price (USD/Unit) of Manufacturers in 2014
Figure Southeast Asia Biologic Drugs Price (USD/Unit) of Manufacturers in 2020
Table Southeast Asia Biologic Drugs Gross Margin of Manufacturers 2014-2020
Figure Southeast Asia Biologic Drugs Gross Margin of Manufacturers in 2014
Figure Southeast Asia Biologic Drugs Gross Margin in 2020
Figure Southeast Asia Biologic Drugs Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table South America Biologic Drugs Sales (K Units) of Manufacturers 2014-2020
Table South America Biologic Drugs Sales Market Share (%) of Manufacturers 2014-2020
Figure South America Biologic Drugs Sales Market Share (%) in 2014
